Category: Firm News

FDA AVANDIA Hearing

  |     |  
Last Modified on Mar 16, 2024

Today, July 13th, 2010, the FDA is currently hosting a hearing regarding the dangerous drug Avandia. Please see our links in MEDIA to view recent news clips from CNN. As Albuquerque personal injury attorneys, we believe Avandia is harmful and consequently should be removed from the market. If you or a loved one has taken… read more


American Dangerous Drug Trials Being Conducted Overseas

  |     |  
Last Modified on Mar 16, 2024

A recent investigative article has disclosed some scary statistics. Even with FDA approval, prescription drugs kill nearly 200,000 Americans each year. As a result of consumer backlash and the raised awareness of the potential risks of dangerous drugs such as Avandia, Reglan, and Darvon/Darvocet, many U.S. drug companies have now moved their clinical trials overseas… read more


Yaz Investigated For Increased Risk Of Blood Clots

  |     |  
Last Modified on Mar 16, 2024

Many types of birth control pills create risks of blood clots. However, new birth control research suggests that certain types of pills create an even higher risk of blood clots than others. Birth control pills that contain Drospirenone – such as Yaz, Yasmin, and Beyaz contain a two to three-time higher risk for developing blot… read more


Avandia Clinical Trials Partially Stopped

  |     |  
Last Modified on Mar 16, 2024

Last week the Food and Drug Administration (FDA) advisory panel recommended that Avandia – a popular diabetes drug linked to a higher risk of heart attack – contain either stronger warning labels or restrict its use. Avandia is developed and manufactured by GlaxoSmithKline. In addition to a well-documented increased risk of heart attack, Avandia has… read more


FDA AVANDIA Hearing – Day Two update

  |     |  
Last Modified on Mar 16, 2024

The officials voting today were presented with multiple choice questions. Question three had a choice of A. The data provides sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Rosiglitazone (Avandia). B. The data does not provide sufficient evidence to raise significant safety concerns in diabetes type 2 patients taking Avandia…. read more


Study Reveals Propecia May Cause Persistent Sexual Dysfunction

  |     |  
Last Modified on Mar 16, 2024

Recent reports have linked finasteride – marketed as Propecia – with persistent and possibly irreversible sexual dysfunction. Propecia, which treats hair loss, works by decreasing the conversion of testosterone to dihydrotestosterone, a hormone that causes hair loss. In fact, doctors have known for years that Propecia has been linked to sexual problems including impotence, but… read more


Yaz Required To Provide New Information On Warning Labels

  |     |  
Last Modified on Mar 16, 2024

The Food and Drug Administration (FDA) has recently issued documents recommending that birth control pills such as Yaz should contain additional warnings concerning the risk of blood clots. The FDA noted that patients and doctors should be informed about the risks. A statement from FDA scientists provides, “We believe that, because of the consistency in… read more



Can Parents Sue For A Vaccine’s Design Defect?

  |     |  
Last Modified on Mar 16, 2024

Last week the United States Supreme Court heard arguments concerning whether the parents of a girl who became sick shortly after being vaccinated against diphtheria, tetanus, and pertussis can sue the vaccine’s manufacturer. The parents allege a design defect. Nearly 5,000 potential lawsuits may result if the court allows the parents to sue, asserting a… read more


Talcum Powder and Ovarian Cancer

  |     |  
Last Modified on Mar 16, 2024

The use of talcum powder in the genital region causes particles of talc to enter the vagina and travel to the uterus, fallopian tubes, and ovaries. The particles reach the ovaries and cause significant irritation that leads to cancer. The first study linking talcum powder and ovarian cancer was published in the 1970s when researchers… read more